Clinical trial Recruiting at 1 site Observational

Longitudinal database for patients with gastroparesis symptoms

Official title: Gastroparesis Outcome Longitudinal Database Enrolled Numerically

Run by University of Louisville · NCT03876288 · Data updated 2026-11-12

This study is tracking patients with gastroparesis symptoms over time to see how their health and quality of life change, regardless of the treatments they receive.

Quick facts

Study typeObservational
SexAll
Enrollment3000 (estimated)
SponsorUniversity of Louisville
Academic / other
Drugs / interventionsImmunotherapy
Locations1 site (Louisville, Kentucky)
StatusRecruiting
StartedJanuary 1, 2013
Main results expectedJanuary 1, 2028
Study endsJanuary 1, 2028
Registry record updatedApril 20, 2026
Trial IDNCT03876288 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with drug-refractory gastroparesis symptoms and disordered nutrition.

Probably not a fit

Patients with anatomic obstruction of the GI tract or psychiatric disorders that hinder assessment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The GOLDEN project is a longitudinal database that tracks patients with symptoms of gastroparesis at the University of Louisville, starting from 2012 and continuing to the present. It includes both current patients and legacy patients from other centers, allowing for comprehensive data collection on symptoms, survival, quality of life, and various health measures over time. The study evaluates outcomes regardless of treatment and stratifies results based on different interventions, including GI neuromodulation and immunotherapy. This extensive data collection aims to provide insights into the management and effects of gastroparesis.

Why it matters

Potential benefit: If successful, this study could enhance understanding of gastroparesis and improve patient management strategies.

How similar studies have gone: Other studies have shown success in tracking outcomes for chronic gastrointestinal conditions, making this approach promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion:

* Patients with the symptoms (Sx) of drug refractory gastroparesis
* Disordered nutrition by standardized assessment
* Ability to assess current symptom status
* Ability to measure other medical conditions

Exclusion:

* Anatomic obstruction of the GI Tract
* Pregnancy
* Inability of patient or guardian to sign informed consent, if needed
* Psychiatric disorders precluding assessment and treatment of the patient's GI condition

Where it's running

  • University of Louisville
    Louisville, Kentucky, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.